Journal for ImmunoTherapy of Cancer Impact Factor, Indexing, Ranking

Journal for ImmunoTherapy of Cancer (JIC) is a scholarly journal dedicated to publishing research in the field of Pharmacology, Toxicology and Pharmaceutics. BMJ is the publisher of this esteemed journal. The P-ISSN assigned to Journal for ImmunoTherapy of Cancer is 2051-1426 and its abbreviated form is J Immunother Cancer.

The Journal for ImmunoTherapy of Cancer (JITC) is the open access, peer reviewed, online journal of the Society for Immunotherapy of Cancer (SITC). The journal publishes articles on all aspects of tumor immunology and cancer immunotherapy and, in doing so, aims to enrich communication and advance scientific understanding among the many stakeholders in this rapidly evolving field. Topics of interest range widely across the basic science-translational-clinical spectrum and include tumor-host interactions, the tumor microenvironment, animal models, predictive and prognostic immune biomarkers, novel pharmaceutical and cellular therapies, vaccines, combination immune-based therapies, and immune-related toxicity.

Journal for ImmunoTherapy of Cancer Abbreviation : ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of Journal for ImmunoTherapy of Cancer Journal is J Immunother Cancer.

The Ranking of Journal for ImmunoTherapy of Cancer in 2026 is 494. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.

The Impact Factor of Journal for ImmunoTherapy of Cancer in 2026 is 10.9. it is all calculated by Clarivate, which means how many times a particular citation has been published in the past two years.

List of All Journal Impact Factors

The SCImago of Journal for ImmunoTherapy of Cancer in 2026 is 3.403. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.

The Acceptance Rate of Journal for ImmunoTherapy of Cancer in 2026 is 23%%. It is a measure that provides insight into the selectivity and competitiveness of a journal's editorial process.

The H-Index of Journal for ImmunoTherapy of Cancer in 2026 is 100. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.

The Quartile of Journal for ImmunoTherapy of Cancer is Q1. A quartile has three points, which are the upper quartile, median, and lower quartile. The main motive of the quartile is to calculate the interquartile range, that resembles the changes across the median.

The Journal for ImmunoTherapy of Cancer is indexed in (Indexing details)

• 1. Web of Science
• 2. UGC
• 3. Scopus
• 4. PubMed
• 5. Medline
• 6. Google Scholar
• 7. Embase
• 8. DOAJ

Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.

The Editor-in-chief of Journal for ImmunoTherapy of Cancer is James L. Gulley, MD, PhD, FACP

Journal for ImmunoTherapy of Cancer Processing/Submission Fee : Article submission/Processing fees (APC), also known as manuscript Publication fees or processing fees (APC), are charged by journals to authors for submitting/publishing their research papers/article.

The APC/Submission (Publication) Fee of Journal for ImmunoTherapy of Cancer is 2885 USD

Journal for ImmunoTherapy of Cancer Call for paper : Journal for ImmunoTherapy of Cancer invites original research contributions for consideration of publication in Journal for ImmunoTherapy of Cancer journal.

Journal seeking submissions in the broad areas of Pharmacology, Toxicology and Pharmaceutics that align with journal's focus on Pharmacology, Toxicology and Pharmaceutics.

for details about call for paper please visit to the official website of the journal to check the details about call for papers.

Publishing in Journal for ImmunoTherapy of Cancer involves the following steps:

• Research: Conduct high-quality, impactful research in the field of Pharmacology, Toxicology and Pharmaceutics.
• Familiarize Yourself: Read and understand the aims and scope of Journal for ImmunoTherapy of Cancer to ensure your work aligns with their focus.
• Manuscript Preparation: Prepare your manuscript according to the Journal for ImmunoTherapy of Cancer guidelines, including formatting, length, and referencing style.
• Submission: Submit your manuscript through the journal's online submission system.

• Journal Website
• PubMed
• Scopus
• SCImago